[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, in Silico, in Vitro and in Vivo Evaluations.

CONCLUSION: The in silico, in vitro and in vivo results justify that [18F]Amylovis should be studied as a promissory PET imaging agent to detect the presence of Aβ senile plaques. PMID: 30605068 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30605068?dopt=Abstract

Source: Current Radiopharmaceuticals - January 5, 2019 Category: Radiology Tags: Curr Radiopharm Source Type: research